The Food and Drug Administration (FDA) is a U.S. government agency within the Department of Health and Human Services. Its primary role is to protect public health, by ensuring safety and effectiveness of drugs, vaccines, medical devices and food products. There are rigorous steps that may take years, and all these steps must be completed before a drug can be approved. The FDA has made some lifesaving investigational drug therapies available sooner than usual by offering an expedited drug approval process, known as “Fast Track”.

I.                  Discuss the process and regulations of Fast Track.

II.               Identify which medical conditions warrant the use of “Fast Track” drugs.

Please pay attention to case study

zero plagiarism

five references

• Provide the case number in the subject line of the Discussion.
• List three questions you might ask the patient if he or she were in your office. Provide a rationale for why you might ask these questions.
• Identify people in the patient’s life you would need to speak to or get feedback from to further assess the patient’s situation. Include specific questions you might ask these people and why.
• Explain what physical exams and diagnostic tests would be appropriate for the patient and how the results would be used.
• List three differential diagnoses for the patient. Identify the one that you think is most likely and explain why.
• List two pharmacologic agents and their dosing that would be appropriate for the patient’s sleep/wake therapy based on pharmacokinetics and pharmacodynamics. From a mechanism of action perspective, provide a rationale for why you might choose one agent over the other.
• If your assigned case includes “check points” (i.e., follow-up data at week 4, 8, 12, etc.), indicate any therapeutic changes that you might make based on the data provided.
• Explain “lessons learned” from this case study, including how you might apply this case to your own practice when providing care to patients with similar clinical presentations.

 

1) **********minimum 3 full pages ( not words)**************************** (cover or reference page not included)

2)¨**********APA norms  (All paragraphs must be narrative and cited in the text- each paragraphs)

3)********** It will be verified by Turnitin and SafeAssign 

4)  Minimum 4 references not older than 5 years  (Only scholarly papers and research or pages from official sources such as CDC, WHO, etc. are accepted)

5) Each answer must be identified according to the question number. Check the list of questions. 

Your answer should start objectively answering the question

___________________________________________________________

Directions

1) Review the clinician provider guidelines and recommendations of the United States Preventive Services Task Force A and B Recommendations. 

https://www.uspreventiveservicestaskforce.org/Page/Name/uspstf-a-and-b-recommendations/

2) Consider you are working in a clinic and need to order a preventive screening on a patient for one of the conditions listed below. (While this is a preventative measure, it also can be a diagnostic tool in other circumstances. 

3) For this Assignment the screening is a secondary prevention measure.

4) Your screening methodology must come from the United States Preventive Services Task Force guidelines.

5) You will demonstrate understanding and correct interpretations of preventive screening guidelines.

______________________________________________________________

Topic: Colon Cancer

Scheme

1 )Find the Final Recommendation Summary for the screening you are evaluating. 

2) Explain the guideline, the correct application of the screening, and the epidemiology behind the guidance. 

3) Content  should include epidemiologic data such as statistical information as available ex. morbidity, mortality, incidence and prevalence of condition. 

4)Identify the methodology and measures for screening. 

5)Include the risk factors, risk assessment, testing interval, description of the patient population,screening test recommendations and other factors relative to the guideline. 

6) Discuss the guideline’s support in a critical analysis, based on the outcomes of studies used in the screening guidance publication. 

7) What key factors are supported by evidence, such as age, methods, measures and intervals? 

8) Consider using the rubric sections as level one headings within the paper.

 

1) **********minimum 3 full pages ( not words)**************************** (cover or reference page not included)

2)¨**********APA norms  (All paragraphs must be narrative and cited in the text- each paragraphs)

3)********** It will be verified by Turnitin and SafeAssign 

4)  Minimum 4 references not older than 5 years  (Only scholarly papers and research or pages from official sources such as CDC, WHO, etc. are accepted)

5) Each answer must be identified according to the question number. Check the list of questions. 

Your answer should start objectively answering the question

___________________________________________________________

Purpose:

1) Formulate a scholarly paper in APA format, providing an overview of the terms and function of EPB. 

2) An introduction, discussion and conclusion is expected in the overview on this topic

Directions:

Using the Cochrane database, research the question using the PICOT model and key words.

1) Formulate the question : will off springs of diabetic patients (P), undergoing thiazolidinedione therapy (I), benefit by not becoming diabetic (O) later in life (T)?

2) Write a page paper, reviewing evidence-based practice, as it relates to your practice question